OBJECTIVE: To describe the postural control of women who received taxane chemotherapy for treatment of breast cancer using quantitative and clinically feasible measures. DESIGN: Prospective descriptive study. SETTING: University-based comprehensive cancer center. PARTICIPANTS: Twenty women who completed taxane treatment for breast cancer and 20 healthy controls participated in this study. INTERVENTIONS: Not applicable. MAIN OUTCOME MEASURES: Two quantitative measures of postural control were used, Sensory Organization Test (SOT) and center of pressure (COP) velocities. Two clinically feasible measures of postural control were used, the Fullerton Advanced Balance Scale (FABS) and Timed Up & Go (TUG) test. RESULTS: Compared with healthy controls, women with breast cancer had poorer postural control on all of the outcome measures. FABS and TUG scores correlated moderately with SOT and COP scores. CONCLUSIONS: After taxane chemotherapy, women with breast cancer show significantly increased postural instability compared with matched controls. Clinically feasible measures of postural control correlated with quantitative tests. These results suggest that these clinical measures may be useful to screen patients to determine who may benefit from rehabilitation.
OBJECTIVE: To describe the postural control of women who received taxane chemotherapy for treatment of breast cancer using quantitative and clinically feasible measures. DESIGN: Prospective descriptive study. SETTING: University-based comprehensive cancer center. PARTICIPANTS: Twenty women who completed taxane treatment for breast cancer and 20 healthy controls participated in this study. INTERVENTIONS: Not applicable. MAIN OUTCOME MEASURES: Two quantitative measures of postural control were used, Sensory Organization Test (SOT) and center of pressure (COP) velocities. Two clinically feasible measures of postural control were used, the Fullerton Advanced Balance Scale (FABS) and Timed Up & Go (TUG) test. RESULTS: Compared with healthy controls, women with breast cancer had poorer postural control on all of the outcome measures. FABS and TUG scores correlated moderately with SOT and COP scores. CONCLUSIONS: After taxane chemotherapy, women with breast cancer show significantly increased postural instability compared with matched controls. Clinically feasible measures of postural control correlated with quantitative tests. These results suggest that these clinical measures may be useful to screen patients to determine who may benefit from rehabilitation.
Authors: Laura S Gilchrist; Mary Lou Galantino; Meredith Wampler; Victoria G Marchese; G Stephen Morris; Kirsten K Ness Journal: Phys Ther Date: 2009-01-15
Authors: Peter C Fino; Fay B Horak; Mahmoud El-Gohary; Carolyn Guidarelli; Mary E Medysky; Sarah J Nagle; Kerri M Winters-Stone Journal: Gait Posture Date: 2019-01-17 Impact factor: 2.840
Authors: Christine Miaskowski; Judy Mastick; Steven M Paul; Kimberly Topp; Betty Smoot; Gary Abrams; Lee-May Chen; Kord M Kober; Yvette P Conley; Margaret Chesney; Kay Bolla; Grace Mausisa; Melissa Mazor; Melisa Wong; Mark Schumacher; Jon D Levine Journal: J Pain Symptom Manage Date: 2017-01-04 Impact factor: 3.612
Authors: Paul Lennart Vollmers; Christoph Mundhenke; Nicolai Maass; Dirk Bauerschlag; Stefan Kratzenstein; Christoph Röcken; Thorsten Schmidt Journal: J Cancer Res Clin Oncol Date: 2018-06-25 Impact factor: 4.553
Authors: Óscar Arrieta; N Hernández-Pedro; M C Fernández-González-Aragón; D Saavedra-Pérez; A D Campos-Parra; M Á Ríos-Trejo; T Cerón-Lizárraga; L Martínez-Barrera; B Pineda; G Ordóñez; A Ortiz-Plata; V Granados-Soto; J Sotelo Journal: Neurology Date: 2011-08-24 Impact factor: 9.910
Authors: Scott M Monfort; Xueliang Pan; Robyn Patrick; Janani Singaravelu; Charles L Loprinzi; Maryam B Lustberg; Ajit M W Chaudhari Journal: Gait Posture Date: 2016-06-14 Impact factor: 2.840